How Recurring Instability Turns into Clinical Trial Delays
In pharma, reliability becomes an operational priority because research and trial work depend on systems performing consistently across different teams, locations, and conditions. Much of that work sits inside scientific workflows, remote sessions, and compute-heavy environments where behaviour can shift with configuration or load. When that consistency starts to break down, teams keep moving, but time is lost in small increments across the day.